Results 171 to 180 of about 6,607 (210)
Some of the next articles are maybe not open access.

Immunotoxins

Annual Review of Immunology, 1985
E S, Vitetta, J W, Uhr
  +5 more sources

[Immunotoxins].

Bulletin du cancer, 1983
Immunotoxins are conjugates between antibodies especially directed against cancer cells and a subunit of a powerful toxin. We used the A-chain of ricin. These conjugates are specifically cytotoxic when used at very low concentrations in vitro and can destroy more than 99.99% of clonogenic cells.
F K, Jansen   +13 more
openaire   +1 more source

Immunotoxins

Cell, 1986
I, Pastan   +2 more
openaire   +2 more sources

Pseudomonas exotoxin — Immunotoxins

1988
Monoclonal antibodies can be coupled with PE to make very potent ITs. Two of these ITs (PE-HB21 and OVB-3-PE) have been shown to have antitumor activity in a nude mouse model of ovarian cancer. PE ITs are at least 10-fold more active than the corresponding RTA IT.
D J, FitzGerald   +2 more
openaire   +2 more sources

Immunotoxins

Scientific American, 1984
R J, Collier, D A, Kaplan
openaire   +2 more sources

Genetic engineering of immunotoxins

1988
Genetic engineering offers many advantages for the 1) production of immunotoxins (ITs) and 2) design of more effective reagents. In Chapter 9, J.R. Murphy discusses the use of genetic engineering to link genes together resulting in chimeric proteins. This review covers the first applications of genetic engineering technology to improve ITs by studying ...
R J, Youle, L, Greenfield, V G, Johnson
openaire   +2 more sources

ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis

European Journal of Surgical Oncology, 2021
Kjersti Flatmark   +2 more
exaly  

Immunotoxins

Clinical Immunotherapeutics, 1994
openaire   +2 more sources

Home - About - Disclaimer - Privacy